Dr. John Cush RheumNow
2 years 11 months ago
Habitually Noncompliant
Seronegative RA - No Show, Won't Go, prn Patient
QD Clinics are sponsored by RheumNows Coverage of #ACR23 live from San Diego
https://t.co/jeD3H9RHvs https://t.co/zIEkecPEu0
Dr. John Cush RheumNow
2 years 11 months ago
RheumNow’s expanded coverage of the #ACR23 Annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty
Dr. John Cush RheumNow
2 years 11 months ago
AI Can Predicts Radiographic Change in RA
The ACR has published a preview of new research from #ACR23 showing that AI & a deep learning system could accurately identify & predict joint space narrowing and erosions in hand radiographs of patients w/ RA.
https://t.co/GGplIcyZLk https://t.co/CVhZfR4gCj
David Liew drdavidliew
2 years 11 months ago
I never tire of hearing this story.
Biologic DMARDs revolutionized rheumatology & changed millions of lives.
How did we get TNFi?
Sharp translational insights & courage++
After 4w, RA gone, up/down stairs like a miracle.
Sir Ravinder 'Tiny' Maini #ACR23 Global Summit @RheumNow https://t.co/Je1cz3cWG5
Dr. John Cush RheumNow
2 years 11 months ago
RheumNow’s expanded coverage of the #ACR23 Annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.
David Liew drdavidliew
2 years 11 months ago
We have a massive rheumatology workforce shortage issue.
Can chatbots help screen/triage patients for rheum diseases?
Enormous potential from this SG🇸🇬 pilot, getting pts to the right care quicker. We need to own & drive this!
@Ninzywong https://t.co/k4m4oQbA5P
#ACR23 @RheumNow https://t.co/RzFnkoez1E
TheDaoIndex KDAO2011
2 years 11 months ago
"Reproductive right is a global issue"- @CuoghiE suggests what Rheums can do:
👉Advocate for legislation to help pts
👉Integrate family planning
👉Prescribe emergency contraception
👉Provide education about reproductive health
#GlobalSummit @ACRheum @RheumNow https://t.co/jLHpzJT2wf
TheDaoIndex KDAO2011
2 years 11 months ago
Dr. del Carmen Zamora-Medina listed several reasons why rheum patients may seek #abortion: teratogenic meds, comorbidities, high disease activity, increased APOs, &women focused reasons. #ACR23 @GlobalSummit #ReproductiveRights @Rheumnow https://t.co/CaH9GVfVvY
Mike Putman EBRheum
2 years 11 months ago
On the way to #ACR23! Would love to meet y'all IRL, please come say hello!
Will be at FIT session, trainee posters (see pics!), moderating Going Viral w/Podcasts, & reporting for @RheumNow
Also, please come watch Knowldege Bowl!! (co-hosting w/@MarkCHwang & @NamrataRheum) https://t.co/jhUj8XASex
TheDaoIndex KDAO2011
2 years 11 months ago
Such contrast to the US!
Mexico’s legislature has de-criminalized abortion, making legal and safe abortions avail to rheum pts #ACR23 #GlobalSummit @Rheumnow @CuoghiE https://t.co/xAezGyav0E
David Liew drdavidliew
2 years 11 months ago
There are lots of reasons why First Nations people might have difficulties with rheumatology care (especially those in remote communities).
Population realities
Healthcare access
Medication access
All have a very real impact on the quality of care we deliver.
#ACR23 @RheumNow https://t.co/qDBsQRWjk9
David Liew drdavidliew
2 years 11 months ago
What did they do in Canada to improve the care for their patients of Indigenous background?
Practical but strategic approach to healthcare service improvement - that lead to real benefits.
#ACR23 @RheumNow https://t.co/VlGW3KBFCj
Dr. John Cush RheumNow
2 years 11 months ago
X-Rays Questioned for Diagnosing Early Rheumatoid Arthritis
Routine hand and foot radiographs in more than 700 patients being evaluated for RA made almost no difference in diagnosing the condition nor in predicting its course, Dutch researchers said.
https://t.co/afU0Td7GOA https://t.co/UCOmBQtpE5
Dr. John Cush RheumNow
2 years 11 months ago
RheumNow’s expanded coverage of the #ACR23 annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty
In a post hoc analysis of the phase 2 NOBILITY trial, researchers found that treatment with obinutuzumab—an antibody that targets a protein expressed on certain immune cells—was superior to placebo for preserving kidney function and preventing flares in patients with lupus nephritis, a kidney condition associated with the autoimmune disease lupus.
